Shellcure Pharmaceuticals Private Limited
About Shellcure Pharmaceuticals Private Limited
Data last updated:
Shellcure Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 January 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U85100PN2015PTC153620. Its GSTIN is 27AAVCS3362B1Z6 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Dhairyashil Uttamrao Shinde and Vikram Uttam Shinde.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Fl No C 204 Sukhanand Complex S No 225/5A Hadapsar, Pune, Maharashtra, India – 411016.
As per the financials filed for FY 2020, the company reported a revenue of ₹7.4 Lakh, a decline of 7% compared to the previous year. For the same year it recorded a net loss of ₹1,784 (net margin -0.2%) and EBITDA of -₹1,713 (EBITDA margin -0.2%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 49% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFl No C 204 Sukhanand Complex S No 225/5A Hadapsar, Pune, Maharashtra, India – 411016
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Shellcure Pharmaceuticals Private Limited
The main business activity of Shellcure Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Shellcure Pharmaceuticals Private Limited FY 2020 filings available
Shellcure Pharmaceuticals Private Limited reported revenue of ₹7.4 Lakh (down 7% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR) of Shellcure Pharmaceuticals Private Limited
Revenue fell 7% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 49%. EBITDA fell 101% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Shellcure Pharmaceuticals Private Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹7.4 Lakh | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1,713 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1,784 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Shellcure Pharmaceuticals Private Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -0.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Shellcure Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Shellcure Pharmaceuticals Private Limited
Shellcure Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mediboon Remedies Private Limited | ₹7.44 Lakh (FY 2025) | •••• | •••• | 264.0% | •••• | Kanpur, Uttar Pradesh, India |
| Alger Pharmaceuticals Private Limited | ₹7.43 Lakh (FY 2025) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Barrex Pharmaceuticals Private Limited | ₹7.43 Lakh (FY 2025) | •••• | •••• | •••• | Thane, Maharashtra, India | |
| Biotech Medicals Private Limited | ₹7.41 Lakh (FY 2025) | •••• | •••• | -83.0% | •••• | Himayatnagar, Hyderabad - 29, Telangana, India |
| Angaj Pharmaceuticals Private Limited | ₹7.4 Lakh (FY 2025) | •••• | •••• | 92.0% | •••• | Sangli, Maharashtra, India |
| Shellcure Pharmaceuticals Private Limited this company | ₹7.4 Lakh (FY 2020) | •••• | •••• | -7.0% | •••• | Pune, Maharashtra, India |
| Asbed Pharmaceuticals Private Limited | ₹7.39 Lakh (FY 2025) | •••• | •••• | 7.0% | •••• | Maninagar, Gujarat, India |
| Triroz Pharmaceuticals Private Limited | ₹7.39 Lakh (FY 2024) | •••• | •••• | 118.0% | •••• | Pune, Maharashtra, India |
| Marselus Pharmaceuticals Private Limited | ₹7.38 Lakh (FY 2025) | •••• | •••• | 380.0% | •••• | D B Nagr, West Bengal, India |
| Shankem Pharmaceuticals Private Limited | ₹7.38 Lakh (FY 2025) | •••• | •••• | -26.0% | •••• | Bharuch, Gujarat, India |
| Asclepios Pharmaceuticals Private Limited | ₹7.37 Lakh (FY 2025) | •••• | •••• | 118.0% | •••• | Agra, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Shellcure Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Shellcure Pharmaceuticals Private Limited
Shellcure Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sushant Balkrishna Navandhar | Additional Director | 30 Jun 2020 | 6 Years 3 Months | Current |
| Dhairyashil Uttamrao Shinde | Director | 06 Jan 2015 | 11 Years 9 Months | Current |
| Vikram Uttam Shinde | Director | 06 Jan 2015 | 11 Years 9 Months | Current |
Ownership and Shareholding of Shellcure Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Shellcure Pharmaceuticals Private Limited
Shellcure Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Shellcure Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Shellcure Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Shellcure Pharmaceuticals Private Limited
Shellcure Pharmaceuticals Private Limited has 3 board changes on record since 2015: 3 appointments. The latest: Sushant Balkrishna Navandhar was appointed as Additional Director on 30 Jun 2020.
Credit Ratings, Litigation & Regulatory Alerts for Shellcure Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Shellcure Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Shellcure Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Shellcure Pharmaceuticals Private Limited
Shellcure Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAVCS3362B1Z6 | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Shellcure Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shellcure Pharmaceuticals Private Limited
Shellcure Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 January 2015 (11+ years old) and is registered under CIN U85100PN2015PTC153620.
Shellcure Pharmaceuticals reported revenue of ₹7.4 Lakh for FY 2020 (down 7% YoY).
Shellcure Pharmaceuticals has 3 current directors:
- Sushant Balkrishna Navandhar - Additional Director
- Dhairyashil Uttamrao Shinde - Director
- Vikram Uttam Shinde - Director
Shellcure Pharmaceuticals reported a net loss of ₹1,784 (net margin -0.2%) and EBITDA of -₹1,713 (EBITDA margin -0.2%) for FY 2020, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Shellcure Pharmaceuticals is 26% over three years and 49% over five years. In the latest year (FY 2020) revenue fell 7%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Shellcure Pharmaceuticals is 27AAVCS3362B1Z6, registered in Maharashtra.
The CIN (Corporate Identification Number) of Shellcure Pharmaceuticals is U85100PN2015PTC153620. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shellcure Pharmaceuticals was incorporated on 06 January 2015, making it 11+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Shellcure Pharmaceuticals by revenue are Mediboon Remedies Private Limited, Alger Pharmaceuticals Private Limited, Barrex Pharmaceuticals Private Limited, Biotech Medicals Private Limited, Angaj Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Sushant Balkrishna Navandhar was appointed as Additional Director on 30 Jun 2020. Dhairyashil Uttamrao Shinde was appointed as Director on 06 Jan 2015. Vikram Uttam Shinde was appointed as Director on 06 Jan 2015.
The registered office of Shellcure Pharmaceuticals is at Fl No C 204 Sukhanand Complex S No 2255A Hadapsar, Pune, Maharashtra, India – 411016.